Detalles de la búsqueda
1.
Acquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockers.
Br J Cancer
; 113(7): 1010-9, 2015 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26372697
2.
Synergistic Effects of Neratinib in Combination With Palbociclib or Miransertib in Brain Cancer Cells.
World J Oncol
; 15(3): 492-505, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38751701
3.
The Combination of Afatinib With Dasatinib or Miransertib Results in Synergistic Growth Inhibition of Stomach Cancer Cells.
World J Oncol
; 15(2): 192-208, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38545471
4.
HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with RAS Wild Type Metastatic Colorectal Cancer.
Cancers (Basel)
; 13(4)2021 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33562755
5.
Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer.
Oncol Rep
; 44(6): 2581-2594, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33125153
6.
Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer.
Oncotarget
; 10(18): 1704-1715, 2019 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30899442
7.
Co-expression and prognostic significance of the HER family members, EGFRvIII, c-MET, CD44 in patients with ovarian cancer.
Oncotarget
; 9(28): 19662-19674, 2018 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-29731973
8.
The impact of co-expression of wild-type EGFR and its ligands determined by immunohistochemistry for response to treatment with cetuximab in patients with metastatic colorectal cancer.
Oncotarget
; 8(5): 7666-7677, 2017 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-28032593
9.
Co-expression of HER family members in patients with Dukes' C and D colon cancer and their impacts on patient prognosis and survival.
PLoS One
; 9(3): e91139, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24609222
10.
Prognostic significance and targeting of HER family in colorectal cancer.
Front Biosci (Landmark Ed)
; 18(2): 394-421, 2013 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23276932
11.
Growth response of human colorectal tumour cell lines to treatment with afatinib (BIBW2992), an irreversible erbB family blocker, and its association with expression of HER family members.
Int J Oncol
; 39(2): 483-91, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21617858
Resultados
1 -
11
de 11
1
Próxima >
>>